Clinical Trial Search

Primary: Intrarater Reliability of Implicit Finger Length Estimates Using the HandUZ Device — 0.91; 0.92 Intraclass Correlation Coefficient

Primary: Eligibility: Number of Patients in the SPIN Cohort Who Meet the Cut-off Thresholds for Eligibility — 24; 16 Participants

Primary: Change in Box and Block Test (BBT) Score at 6 Months Post-Treatment — 13.5; 12.6; 9.6 blocks

Primary: Patient's Assessment of General Well-being During the Last 24 Hours (Diaries; ReQuest™ in Practice) — 5.31; 4.60; 3.67; 2.95 Units on a scale

Primary: Australian/Canadian Hand Osteoarthritis Index (AUSCAN NR3.1) Pain Subdomain Score: Change From Baseline to Week 16 — -10.74; -9.22 units on a scale — p=0.386

Primary: Number of Patients Who Completed the Hand Rehabilitation Program — 14; 13 participants

Primary: Control Period-Count the Number of Baseline Colony Forming Units Cultured From Anesthesiologist's Hands — 589.3 Colony forming units

Primary: Change in 6-minute Walk Test — 22; 49 meters

Primary: Treatment Adherence — 24; 18 Participants

Primary: Foam Sanitizer Wet Time Duration — 35.41 time in seconds

Primary: Percentage of Participants Who Experience Each Treatment Emergent Adverse Event Experienced by ≥5% of Participants During the 8-week Healing Treatment Period — 6.5; 6.5…

Primary: Percentage of Participants With Recurrence of Erosive Esophagitis as Confirmed on Endoscopy After the 24-week Maintenance Phase — 13.3; 12.3; 25.5 percentage of…

Primary: Total Ghent University Scoring System (GUSS) of Target Joints at Week 24 — 162.2; 153.3 units on a scale — p=0.024

Primary: Short-latency Afferent Inhibition — 48; 21 % of unconditioned motor evoked potentia

Primary: Change From Baseline in Fugl Meyer Upper Extremity Scale at Post Treatment — 35.25; 33.5 score on a scale — p=0.046